Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis.

Cell Death Dis · 2026 · PMC13315729 · PMID 42373608

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marginal trendno p-value reported

Our results show that, in the BRCA‐WT tumor cohort, EZH2 exhibited only a marginal trend for overall survival and no association with progression‐free survival.

also in 626 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.